Latest Breaking News On - Exchange regulation ltd - Page 1 : comparemela.com

Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 25, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May 2023 financial key figures: Revenue from contracts with customers of CHF 103.4 million (2022: CHF 7.5 million) Net result of CHF 54.8 million (2022: CHF -71.1 million) Cash flow from operating

United statesUnited kingdomSwitzerland generalShabir hashamDario eklundAndrew smithEva kaliasChiesi farmaceuticiAmerica to catalyst pharmaceuticals incLife science allianceNational institute for healthSanthera pharmaceuticals holdingCatalyst pharmaceuticals incExchange regulation ltdRegulatory agencySanthera pharmaceuticals holding ltd

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomSwitzerland generalUnited statesDennis riedlEva kaliasDario eklundShabir hashamChiesi farmaceuticiAndrew smithSanthera pharmaceuticalsChina national medical products administrationCatalyst pharmaceuticalsHead investor relations communicationsExchange regulationEuropean medicines agencyEuropean union summary of product characteristics

Ad hoc announcement: GAM Holding AG - Deferral of publication of the Annual Report 2022 announced on 24 April 2023 approved

2 May 2023 PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM Holding AG: Deferral of publication of the Annual Report 2022 announced on 24 April 2023,approved by SIX

New yorkUnited statesUnited kingdomCity ofHong kongPublikationdes geschUte dehn christenCharles naylorSwiss exchangeFund management servicesHead of communicationsExchange regulation ltdExchange regulationAnnual reportEinreichung des geschRegulation ltd

Ad hoc announcement pursuant to Art 53 listing rules: GAM Holding AG - Deferral of publication of the Annual Report 2022 announced on 24 April 2023, approved by SIX Exchange Regulation AG

2 May 2023 Ad hoc announcement pursuant to Art. 53 listing rules: GAM Holding AG - Deferral of publication of the Annual Report 2022 announced on 24 April 2023, approved by SIX. | May 2, 2023

United kingdomHong kongCity ofNew yorkUnited statesUte dehn christenCharles naylorExchange regulation ltdSwiss exchangeFund management servicesGlobal head of communicationsExchange regulationAnnual reportPublikation des geschEinreichung des geschRegulation ltd

Santhera Announces Preliminary Unaudited 2022 Annual Results Ahead of Full Report Publication by End of May and Provides Corporate Update

Santhera Announces Preliminary Unaudited 2022 Annual Results Ahead of Full Report Publication by End of May and Provides Corporate Update Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 27, 2023, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news releas.

Switzerland generalUnited kingdomUnited statesAndrew smithDario eklundShabir hashamBradley meyerEva kaliasStrategy committeeSanthera pharmaceuticals holding ltdSanthera pharmaceuticalsEuropean commissionExchange regulation ltdCommittee for medicinal products human useHighbridge capital managementEuropean union